Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

Naranjo

Busto

Sellers

et al . A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.

Tuttle

McKinney

Davidson

Anglin

Harper

Botros

FT.

Effects of one-weekly dulaglutide on kidney function in patients with type 2 diabetes in phase II and III clinical trials. Diabetes Obes Metab. 2017;19:436-441. doi:10.1111/dom.12816.

Nandakoban

Furlong

Flack

JR.

Acute tubulointerstitial nephritis following treatment with exenatide. Diabet Med. 2013;30:123-125. doi:10.1111/j.1464-5491.2012.03738.x.

Kaakeh

Kanhee

Boone

Sutton

Liraglutide-induced acute kidney injury. Pharmacotherapy. 2012;32:e7-e11. doi:10.1002/PHAR.1014.

Weise

Sivanandy

Block

Comi

RJ.

Exenatide associated ischemic renal failure. Diabetes Care. 2009;32(2):e22-e23. doi:10.2337/dc08-1309.

Acute Kidney Injury Occurring in a Patient Initiated on Dulaglutide

Abstract

Get full access to this article

References